%0
Generic
%T
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study
%A Mall, Marcus A.
%A Brugha, Rossa
%A Gartner, Silvia
%A Legg, Julian
%A Moeller, Alexander
%A Mondejar-Lopez, Pedro
%A Prais, Dario
%A Pressler, Tacjana
%A Ratjen, Felix
%A Reix, Philippe
%A Robinson, Paul D.
%A Selvadurai, Hiran
%A Stehling, Florian
%A Ahluwalia, Neil
%A Arteaga-Solis, Emilio
%A Bruinsma, Bote G.
%A Jennings, Mark
%A Moskowitz, Samuel M.
%A Noel, Sabrina
%A Tian, Simon
%A Weinstock, Tanya G.
%A Wu, Pan
%A Wainwright, Claire E.
%A Davies, Jane C.
%I American Thoracic Society
%@ 1073-449X
%@ 1535-4970
%D 2022
%C American Thoracic Society
%U http://slubdd.de/katalog?TN_libero_mab2